Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular toxicity associated with systemic drug therapy.

R S Moorthy1, S Valluri

  • 1Indiana University School of Medicine, Indianapolis, USA.

Current Opinion in Ophthalmology
|February 8, 2000
PubMed
Summary

Systemic drugs can cause eye side effects. A review found high causality for ocular toxicity with several common drugs, excluding vigabatrin and statins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRANSVAGINAL SONOGRAPHY.

Medical journal, Armed Forces India·2017
Same author

Radiological Quiz.

Medical journal, Armed Forces India·2016
Same author

Rounded Atelectasis - A Case Report.

Medical journal, Armed Forces India·2016
Same author

Conventional B-mode Ultrasonography for Evaluation of Retinal Disorders.

Medical journal, Armed Forces India·2016
Same author

DOPPLER ULTRASOUND.

Medical journal, Armed Forces India·2016
Same author

A rare tumour of pancreas in an incidentally discovered pancreatic lipoma.

Medical journal, Armed Forces India·2015

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Toxicology

Background:

  • The incidence of systemic drug-induced ocular side effects is rising due to new drug development.
  • Accurate documentation and exclusion of alternative causes are crucial for establishing causality in drug-induced ocular toxicity.
  • Systemic medications are increasingly associated with adverse ocular events.

Purpose of the Study:

  • To evaluate the causality of ocular toxicity for commonly used and newly introduced systemic drugs.
  • To review recent reports implicating systemic drugs in ocular toxicity.
  • To summarize detection, prevention, and treatment strategies for drug-induced ocular reactions.

Main Methods:

  • Systematic review of recent literature on ocular toxicity associated with systemic drugs.
  • Application of toxicologic criteria to establish causality for drug-induced ocular side effects.
  • Evaluation of ocular toxicity reports for specific systemic agents including cidofovir, sildenafil, vigabatrin, tamoxifen, hydroxychloroquine/chloroquine, amiodarone, and statins.

Main Results:

  • High probability of causality for ocular toxicity was established for cidofovir, sildenafil, tamoxifen, hydroxychloroquine/chloroquine, and amiodarone.
  • Vigabatrin and lovastatin/simvastatin showed a lower probability of causality for ocular toxicity based on the evaluated criteria.
  • The review identified specific ocular toxicities linked to each evaluated drug.

Conclusions:

  • Several commonly prescribed systemic drugs carry a high risk of causing ocular toxicity.
  • Vigabatrin and statins (lovastatin/simvastatin) were less likely to be causative agents for ocular toxicity in this review.
  • Understanding these risks is vital for clinicians to manage and prevent adverse ocular events in patients on systemic medications.

Related Experiment Videos